Internal Medicine, Rheumatology · Miami, FL
NPI
1710173794
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
351 NW 42nd Ave, Suite 404
Miami, FL, 33126
Phone (305) 856-5733
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
8,512 services
Medicare patients, 2024
80
Average age 77
Drug cost, 2024
$14.2M
11,853 prescriptions
Company payments, 2025
$3,425
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose J Aldrich was code J1010 (injection, methylprednisolone acetate, 1 mg), 7,729 times for 62 patients. In total Jose J Aldrich billed 8,512 services in 13 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 7,729 | 62 | $0.10 | $787 |
| 20610 Joint Injection | Office | 231 | 65 | $68.40 | $16K |
| 99213 Office E&M - Established | Office | 154 | 59 | $70.22 | $11K |
| 99214 Office E&M - Established | Office | 119 | 50 | $101.13 | $12K |
| 20605 Joint Injection | Office | 107 | 42 | $34.55 | $3,697 |
| J1030 Injection, methylprednisolone acetate, 40 mg | Office | 96 | 45 | $4.53 | $435 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 19 | $13.67 | $301 |
| 99204 Office E&M - New | Office | 19 | 19 | $127.00 | $2,413 |
| 20552 Musculoskeletal | Office | 18 | 16 | $33.70 | $607 |
By year: 2022 $60K for 1,212 services; 2023 $63K for 1,241 services; 2024 $47K for 8,512 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose J Aldrich prescribed most often to Medicare patients was Baclofen, with 1,095 prescriptions and refills. In total Jose J Aldrich wrote 11,853 Medicare prescriptions that cost $14.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 1,095 | 1,463 | 424 | $11K |
| Methotrexate Methotrexate Sodium | 1,095 | 1,270 | 204 | $5,143 |
| Meloxicam Generic | 781 | 868 | 269 | $1,478 |
| Gabapentin Generic | 780 | 897 | 261 | $6,418 |
| Prednisone Generic | 759 | 861 | 181 | $2,418 |
| Tramadol Hcl Generic | 551 | 559 | 164 | $4,619 |
| Prolia Denosumab | 512 | 3,069 | 334 | $902K |
| Folic Acid Generic | 508 | 761 | 121 | $1,404 |
| Diclofenac Sodium Generic | 467 | 502 | 128 | $11K |
| Nabumetone Generic | 394 | 416 | 158 | $3,680 |
| Rinvoq Upadacitinib | 356 | 356 | 44 | $2.3M |
| Humira(Cf) Pen Adalimumab | 332 | 332 | 45 | $2.3M |
| Hydroxychloroquine Sulfate Generic | 293 | 395 | 63 | $4,117 |
| Enbrel Sureclick Etanercept | 289 | 289 | 43 | $2.2M |
| Pregabalin Generic | 224 | 237 | 59 | $7,049 |
Brand drugs: - claims; generic drugs: 9,295 claims; opioid claims: 921.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose J Aldrich $3,425 ($3,425 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $885.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 35 | $885 |
| Mallinckrodt Hospital Products Inc. | 19 | $398 |
| UCB, Inc. UCB.BR | 12 | $358 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $333 |
| ANI Pharmaceuticals, Inc. ANIP | 15 | $331 |
| Amgen Inc. AMGN | 15 | $304 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $194 |
| Pfizer Inc. PFE | 8 | $181 |
| Janssen Biotech, Inc. JNJ | 8 | $141 |
| GlaxoSmithKline, LLC. GSK | 7 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.